Fumarate hydratase–deficient renal cell carcinoma (fhRCC) is characterized by loss of the FH gene and was first identified as part of the inherited disease hereditary leiomyomatosis and renal cell cancer (HLRCC) in which patients have a germline loss of FH function. This evidence concerns the gene FH and hereditary disease.